Blocking of HIV-1 infection, but not HIV-1-induced syncytium formation, by a CD4 peptide derivative partly corresponding to an immunoglobulin CDR3.
Ohki
K
K
Kimura
T
T
Ohmura
K
K
Kato
S
S
Ikuta
K
K
D015704:CD4 Antigens / Q000378:metabolism / Q000494:pharmacology*; D002460:Cell Line; D015726:Giant Cells / Q000166:cytology / Q000187:drug effects*; D015700:HIV Envelope Protein gp41 / Q000378:metabolism; D015497:HIV-1 / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007136:Immunoglobulins; D010455:Peptides / Q000378:metabolism / Q000494:pharmacology*
D015704:CD4 Antigens; D015700:HIV Envelope Protein gp41; D007136:Immunoglobulins; D010455:Peptides